DP Eurasia N.V Ret. on equity
What is the Ret. on equity of DP Eurasia N.V?
The Ret. on equity of DP Eurasia N.V. is -69.03%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Consumer Discretionary sector on LSE compared to DP Eurasia N.V
What does DP Eurasia N.V do?
DP Eurasia N.V. operates corporate-owned and franchised stores under the Domino's Pizza brand in Turkey, Russia, Azerbaijan, and Georgia. The company offers pizza delivery and takeaway services. As of December 31, 2021, it operated 809 stores, including 615 franchised stores and 194 corporate-owned stores. The company was founded in 1996 and is based in Amsterdam, the Netherlands.
Companies with ret. on equity similar to DP Eurasia N.V
- Apergy has Ret. on equity of -69.22%
- Biomerica has Ret. on equity of -69.21%
- Killi Resources Ltd has Ret. on equity of -69.15%
- Pioneer Credit has Ret. on equity of -69.13%
- Black Diamond Therapeutics Inc has Ret. on equity of -69.08%
- Mirada Plc has Ret. on equity of -69.07%
- DP Eurasia N.V has Ret. on equity of -69.03%
- Inozyme Pharma has Ret. on equity of -68.93%
- Simplex Castings has Ret. on equity of -68.87%
- Dyne Therapeutics has Ret. on equity of -68.85%
- Kronos Bio has Ret. on equity of -68.82%
- Tisdale Resources has Ret. on equity of -68.82%
- Cancer Genetics has Ret. on equity of -68.71%